| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | SALE Chairman and CEO | 92,746 | — | — | 0 | May 21, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | PURCHASE Chairman and CEO | 92,746 | — | — | 405,280 | May 21, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | SALE Chairman and CEO | 95,575 | — | — | 0 | May 21, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | PURCHASE Chairman and CEO | 95,575 | — | — | 1,193,569 | May 21, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | PURCHASEGRANT Stock grant | 103,364 | — | — | 103,364 | May 20, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | PURCHASEGRANT Stock grant | 92,746 | — | — | 92,746 | May 20, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | PURCHASEGRANT Stock grant | 95,575 | — | — | 95,575 | May 20, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | PURCHASEGRANT Stock grant | 214,999 | — | — | 214,999 | May 20, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | PURCHASEGRANT Stock grant | 214,988 | — | — | 214,988 | May 20, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | PURCHASEGRANT Stock grant | 298,194 | — | — | 298,194 | May 20, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | PURCHASEGRANT Stock grant | 103,365 | — | — | 103,365 | May 20, 2026 | May 22, 2026 ↗ |
| AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | PURCHASEGRANT Stock grant | 298,195 | — | — | 0 | May 20, 2026 | May 22, 2026 ↗ |